Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach? [Review article]

MLA

D. Ripin, et al. “Protease Inhibitor-Containing Antiretroviral Treatment and Tuberculosis: Can Rifabutin Fill the Breach? [Review Article].” The International Journal of Tuberculosis and Lung Disease, vol. 16, Jan. 2012, pp. 6–15. EBSCOhost, https://doi.org/10.5588/ijtld.10.0626.

APA

D. Ripin, Charles F. Gilks, Amitabh B. Suthar, Brian G. Williams, F. Renaud-Thery, Reuben Granich, Philippe Glaziou, Renee Ridzon, M. O’Brien, A. Loeliger, & Siobhan Crowley. (2012). Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach? [Review article]. The International Journal of Tuberculosis and Lung Disease, 16, 6–15. https://doi.org/10.5588/ijtld.10.0626

Chicago

D. Ripin, Charles F. Gilks, Amitabh B. Suthar, Brian G. Williams, F. Renaud-Thery, Reuben Granich, Philippe Glaziou, et al. 2012. “Protease Inhibitor-Containing Antiretroviral Treatment and Tuberculosis: Can Rifabutin Fill the Breach? [Review Article].” The International Journal of Tuberculosis and Lung Disease 16 (January): 6–15. doi:10.5588/ijtld.10.0626.